Jean-Christophe Ianotto

21PUBLICATIONS
102CO-AUTHORS
Medical infection agents (incl. prions)Respiratory diseasesHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Aug 04, 2026
Non-invasive multiparametric characterization of essential thrombocythemia, premyelofibrosis, and overt myelofibrosis.

|May 13, 2026
Impact of Atrial Fibrillation on Thrombotic Complications in Myeloproliferative Neoplasms Real-World Analysis.

|Dec 23, 2025
Thromboinflammation is associated with high thrombotic risk in patients with newly diagnosed myeloproliferative neoplasms.

Alexandre Guy, Olivier Mansier, Matisse Decilap

|Dec 15, 2025
Ruxolitinib and Hydroxycarbamide Are the Most Efficient Drugs to Reduce Aquagenic Pruritus Intensity in a Real-Word Cohort of Patients With Myeloproliferative Neoplasms.

Christelle Le Gall-Ianotto, Lanig Civi, Brigitte Pan-Petesch

|Oct 17, 2025
Coexisting Myeloproliferative and Lymphoid Neoplasms: A European Multicenter Retrospective Study.

Dolly Viviana Fiallo-Suárez, Ruth Stuckey, Cristina Bilbao-Sieyro

|Jun 18, 2025
A molecular signature predicts hematologic evolution in polycythemia vera patients.

Olivier Mansier, Eric Lippert, Lina Benajiba

Pageof 4

Frequent Collaborators

7 joint publications

Eric Lippert

7 joint publications

Damien Luque Paz

5 joint publications

Jérémie Riou

5 joint publications

Léa Sureau